CCM
CL icon

Campbell Capital Management’s Colgate-Palmolive CL Stock Holding History

Campbell Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10
Closed -$909 – 68
2024
Q4 		$909 Buy
+10
New +$954 ﹤0.01% 87

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Campbell Capital Management's CL Position: Q1 2025 in Review

Campbell Capital Management sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 10 shares — an estimated $909 sold.

Campbell Capital Management first reported a position in CL in Q4 2024 and held it in 1 quarter. The position peaked at $909 in Q4 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Campbell Capital Management reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Campbell Capital Management sold 10 Colgate-Palmolive shares in Q1 2025, an estimated $909.
  • Campbell Capital Management first reported a position in Colgate-Palmolive in Q4 2024 and held it in 1 quarter.
  • Campbell Capital Management's Colgate-Palmolive position peaked at $909 in Q4 2024.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Campbell Capital Management's 13F filing for Q1 2025, filed 9 May 2025.